Bringing Hope to Children and Young People with Hardest to Treat Cancers
Terry Fox PROFYLE (PRecision Oncology For Young peopLE) was launched in 2017 with a goal of using precision medicine to deliver new treatment options to infants, children, and young people with hard-to-treat cancers. This unique program has quickly become the most ambitious childhood cancer initiative ever undertaken in Canada. It is this county’s first ever collaborative, national personalized medicine program for patients aged 0-29 and includes over 30 pediatric cancer research and funding organizations working together to guide diagnosis and treatment.
Patients who are enrolled in Terry Fox PROFYLE have their tumours genetically sequenced. This powerful process can uncover molecular signatures that allow researchers and clinicians to offer new treatment options for these young patients.
Terry Fox PROFYLE exists for the young cancer patients who have been told they are out of treatment options. Together, we can provide more time, more options…and more hope.
We need your help. Together we can help these young patients and improve Canada’s pediatric cancer model.